Cargando…

Hyaluronan and LYVE-1 and allograft function in lung transplantation recipients

Hyaluronan (HA) is associated with innate immune response activation and may be a marker of allograft dysfunction in lung transplant recipients. This was a prospective, single center study comparing levels of bronchioalveolar lavage (BAL) and serum HA and the HA immobilizer LYVE-1 in lung transplant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Courtwright, Andrew M., Lamattina, Anthony M., Louis, Pierce H., Trindade, Anil J., Burkett, Patrick, Imani, Jewel, Shrestha, Shikshya, Divo, Miguel, Keller, Steve, Rosas, Ivan O., Goldberg, Hilary J., El-Chemaly, Souheil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588572/ https://www.ncbi.nlm.nih.gov/pubmed/31227795 http://dx.doi.org/10.1038/s41598-019-45309-6

Ejemplares similares

FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake
por: Shrestha, Shikshya, et al.
Publicado: (2020)

Blocking hyaluronan synthesis alleviates acute lung allograft rejection
por: Imani, Jewel, et al.
Publicado: (2021)

Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survival
por: Courtwright, Andrew M., et al.
Publicado: (2020)

Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion
por: Esposito, Anthony J, et al.
Publicado: (2023)

Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosis
por: Lamattina, Anthony M., et al.
Publicado: (2019)

Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres
por: Trindade, Anil J., et al.
Publicado: (2020)

Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell death
por: Shrestha, Shikshya, et al.
Publicado: (2022)

Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization
por: Lawrance, William, et al.
Publicado: (2016)

The cortical actin network regulates avidity-dependent binding of hyaluronan by the lymphatic vessel endothelial receptor LYVE-1
por: Stanly, Tess A., et al.
Publicado: (2020)

The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis
por: Courtwright, Andrew M., et al.
Publicado: (2017)

Low Molecular Weight Hyaluronan Induces Lymphangiogenesis through LYVE-1-Mediated Signaling Pathways
por: Wu, Man, et al.
Publicado: (2014)

Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways
por: Stump, Benjamin, et al.
Publicado: (2019)

1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease
por: Trindade, Anil J., et al.
Publicado: (2021)

LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan
por: Banerji, Suneale, et al.
Publicado: (1999)

ETV2 regulates PARP-1 binding protein to induce ER stress–mediated death in tuberin-deficient cells
por: Shrestha, Shikshya, et al.
Publicado: (2022)

Prostaglandin E(2) Boosts the Hyaluronan-Mediated Increase in Inflammatory Response to Lipopolysaccharide by Enhancing Lyve1 Expression
por: Hog, Pauline, et al.
Publicado: (2023)

The Interaction between LYVE-1 with Hyaluronan on the Cell Surface May Play a Role in the Diversity of Adhesion to Cancer Cells
por: Du, Yan, et al.
Publicado: (2013)

Association of Donor and Recipient Telomere Length with Clinical Outcomes following Lung Transplantation
por: Courtwright, Andrew M., et al.
Publicado: (2016)

Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility
por: Imani, Jewel, et al.
Publicado: (2022)

Homodimerization of the Lymph Vessel Endothelial Receptor LYVE-1 through a Redox-labile Disulfide Is Critical for Hyaluronan Binding in Lymphatic Endothelium
por: Banerji, Suneale, et al.
Publicado: (2016)

Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells
por: Burger, Fabienne, et al.
Publicado: (2022)

Deciphering the heterogeneity of the Lyve1(+) perivascular macrophages in the mouse brain
por: Siret, C., et al.
Publicado: (2022)

Lymphatic Vascularisation and Involvement of Lyve-1(+) Macrophages in the Human Onchocerca Nodule
por: Attout, Tarik, et al.
Publicado: (2009)

Histological Study and LYVE-1 Immunolocalization of Mouse Mesenteric Lymph Nodes with “In Vivo Cryotechnique”
por: Bai, Yuqin, et al.
Publicado: (2011)

A Comparative Analysis of the Lyve-SET Phylogenomics Pipeline for Genomic Epidemiology of Foodborne Pathogens
por: Katz, Lee S., et al.
Publicado: (2017)

A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity
por: Kato, T, et al.
Publicado: (2005)

Serum sLYVE-1 is not associated with coronary disease but with renal dysfunction: a retrospective study
por: Dai, Daopeng, et al.
Publicado: (2019)

LYVE1(+) macrophages of murine peritoneal mesothelium promote omentum-independent ovarian tumor growth
por: Zhang, Nan, et al.
Publicado: (2021)

Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles
por: Guo, Qiu, et al.
Publicado: (2013)

LYVE1 Marks the Divergence of Yolk Sac Definitive Hemogenic Endothelium from the Primitive Erythroid Lineage
por: Lee, Lydia K., et al.
Publicado: (2016)

Lyve-1 deficiency enhances the hepatic immune microenvironment entailing altered susceptibility to melanoma liver metastasis
por: Jauch, Anna Sophia, et al.
Publicado: (2022)

Zygomycosis in a renal allograft recipient
por: Lakshminarayana, G., et al.
Publicado: (2009)

Mycobacterial disease in renal allograft recipients
por: Ardalan, Mohammad-Reza
Publicado: (2013)

Chromoblastomycosis in a renal allograft recipient
por: Sooraj, Y. S., et al.
Publicado: (2013)

Intra-articular hyaluronans: the treatment of knee pain in osteoarthritis
por: Goldberg, Victor M, et al.
Publicado: (2010)

Immunohistochemical Examination on the Distribution of Cells Expressed Lymphatic Endothelial Marker Podoplanin and LYVE-1 in the Mouse Tongue Tissue
por: Noda, Yuya, et al.
Publicado: (2010)

hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492
por: Feng, Zhenzhen, et al.
Publicado: (2023)

Inpatient Kidney Palliative Care for Kidney Transplant Recipients With Failing Allografts
por: Murakami, Naoka, et al.
Publicado: (2021)

Pulmonary histoplasmosis in a renal allograft recipient
por: Lobo, V., et al.
Publicado: (2014)

Adefovir nephrotoxicity in a renal allograft recipient
por: George, N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vv9j6ntpbjmho6cqcrl78arhe8